Putting cosmeceuticals in context ‘Handbook of cosmeceutical excipients and their safeties’, by Kwan Yu Heng, Tung Yee Kei, Kochhar Jaspreet Singh, Li Hairui, Poh Ai-Ling and Kang Lifeng.…
US healthcare groups recommend ways of tackling ongoing drug shortages Recommendations for addressing ongoing shortages of essential medicines have been made by a group of US healthcare organisations.…
Medicines regulator warns over unlicensed blood plasma productAn unlicensed medicine sold via European websites and which claims to treat HIV, cancer and autism, contains blood plasma never intended for human use.…
Drug shortages: it’s time for Europe to act Unlike the United States, Europe has no plan for coordinated action to mitigate drug shortages.…
Moorfields Eye Hospital to close its specials manufacturing facilityMoorfields Eye Hospital NHS Foundation Trust has decided to close its specials manufacturing facility in London, its board has announced.…
EMA recommends suspending licences for 700 drugs over flawed analyses by GVK BiosciencesThe European Medicines Agency is recommending that the marketing authorisation be suspended for more than 700 generic products tested by GVK Biosciences.…
Gold standard guidance on injectable drugs ‘Handbook on injectable drugs, 18th edition’, editor-in-chief Gerald K McEvoy.…
Learn about dosage form design ‘Design and manufacture of pharmaceutical tablets’, by Reynir Eyjolfsson.…
A complete reference guide to vaccine production ‘Vaccine Development and Manufacturing’, edited by Emily P Wen, Ronald Ellis, Narahari S Pujar.…
Targeting disease in the developing world A new report by the Access to Medicine Index finds that pharmaceutical companies influence access to medicines in developing countries through the development of innovative and adapted products, operating equitable pricing strategies and building local capacity.…
